250 likes | 360 Views
Contribution of Iran and Turkey to the World Medical Science. Prof. Sadegh Massarrat , MD Dr. Shadi Kolahdoozan, MD. Method.
E N D
Contribution of Iran and Turkey to the World Medical Science Prof. SadeghMassarrat, MD Dr. Shadi Kolahdoozan, MD
Method Only English journals fulfilled the qualification criteria to be indexed by the ISI with known impact factors (IF) announced at beginning of 2010 were included for evaluation. We calculated the number of all articles published from the beginning of 2007 up to October 2010, the number of total citations and citations from authors outside Iran and Turkey for each journal. We although selected all articles cited at least 6 times by authors outside both countries and analyzed their contents in relation to the originality and the novelty as well as their contribution to the present knowledge.
Method For evaluation of scientific contribution of both countries 61 out of 310 international journals with impact factor of 6 or more with high clinical and basic importance were selected and articles from Iran and Turkey published during 2007 up to october 2010 were chosen .
Results Among 154 approved Iranian journals, 46 are only in English, Twenty-one out 46 English journals are indexed in ISI. Twelve of ISI-indexed Iranian journals, published since 2007 have known IF. Turkey has 28 ISI-indexed English journals, 15 of them 0nly have known impact factor.
Iranian journals in ISI indexed system with known impact factor (2007-2010)
Iranian journals in ISI indexed system with known impact factor (2007-2010)
Turkish journals in ISI indexed system with known impact factor (2007-2010)
Turkish journals in ISI indexed system with known impact factor (2007-2010)
Comparison of Contribution of Iran and Turkey to Medical Sciences in ISI indexed Journals (2007-2010) *: Only 9 of 25 articles in Turkish and 7 of 8 articles in Iranian journals are from domestic authors
Highly cited articles from Iranian Scientists in Iranian journals (≥ 6 times)
Highly cited articles from Iranian Scientists in Iranian journals (≥ 6 times)
Highly cited articles from Turkish Scientists in Turkish journals (≥ 6 times)
Highly cited articles from Turkish Scientists in Turkish journals (≥ 6 times)
Highly cited articles from Turkish Scientists in Turkish journals (≥ 6 times)
Highly cited articles from Turkish Scientists in Turkish journals (≥ 6 times)
Contribution of Medical Sciencse in International Journals with high Impact Factors (≥ 6) published during 2007-Oct. 2010
Conclusion 1- English Medical Journals from Iran and Turkey have very low impact factors 2-Every one out 3 articles from Turkey and every one out of 5 articles from Iran are cited only one time by foreign authors.
Conclusion 3- Scientists of both countries prefer to publish their valuable works in international journals with high reputation 4- As very few articles in Iranian or Turkish English journals had high citation rate, the lack of citation of other articles by foreign authors is due to low quality of their contents 5-Articles from Turkey have lower self-citation rate than that of Iran (33% vs 62%).
Conclusion 6- By the same high quality ,Turkey had 60% more high quality studies, especially randomized controlled trials, published in high reputation journals than Iran. 7- Randomized clinical studies , new drug regimen studies or diseases of the regions, but not research in basic science have high citation by foreign authors
چه بايد کرد؟ 1- تعداد مجلات پزشکي ما بسيار زياد و محتويات آن کم ارزش بوده و قابل توجه قرار نمي گيرد بايد همه مجلات با ارجاع کم حذف يا چند مجله با هم ادغام گردند. 2- محتويات مجلات پزشکي تقليد يا کپي کارهاي علمي انجام شده در جهان است محققين ايراني بايد از انجام بررسي هاي منتشر شده در کشورهاي غربي براي تائيد يا رد با متدلوژي جديد و تعداد کم افراد قويا اجتناب کنند.
3- مجلات نبايد بوسيله افراد يا يک موسسه تحقيقاتي يا يک دانشگاه انتشار گردد بلکه به وسيله انجمن هاي تخصصي که تعداد متخصصين در آن اشتراک منافع صنفي و علمي دارند منتشر شوند. 4- از انتشار چند مجله در يک رشته اختصاصي خود داري شود. 5- انتشار مقالات براي ارتقاء علمي در سطوح پائين دانشگاه نبايد الزامي گردد .
6- مسائل و مشکلات سلامتي جامعه و بيماريهاي منطقه اي با انجام مطالعات طولاني مدت و انجام بررسي هاي باليني کنترل شده بايد مورد توجه تحقيقات قرار گيرد و نتايج اين تحقيقات مي تواند براي جامعه مفيد و با ارزش باشد. 7- با پيروي از چنين استراتژي ممالک جهان سوم از جمله ترکيه و ايران مي توانند سهم مهمي در پيشرفت جهان علم داشته باشند. 8- کشور چين تازه به اهميت نکات بالا پي برده و مقدمات محدوديت انتشارات پزشکي را با جديت مورد بررسي قرار داده است.